Trial Profile
Treatment with recombinant Streptokinase in the acute haemorrhoidal disease.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Oct 2020
Price :
$35
*
At a glance
- Drugs Streptokinase (Primary)
- Indications Haemorrhoids; Thrombosis
- Focus Adverse reactions; Pharmacodynamics
- Acronyms THERESA
- 31 Jul 2013 Status changed from active, no longer recruiting to completed as reported by Cuban Clinical Trial Registry.
- 08 Sep 2011 New trial record